David Scadden

CIK 1707715 · last filed 2025-11-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$518.6K

Companies

4

Total Filings

34

Lifetime Open-Market Net

$17.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AGIO Director 17,603 $29.46 $518.6K -$81.5K 21 2025-11-14
EDIT Director $2.50 $0 7 2025-06-10
CARM Director $0.00 $0 1 2024-07-01
Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Director 802,074 $11.19 $8.98M $99.0K 5 2022-06-30

Recent Filings · Page 3 of 4

34 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-03 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Grant (A) $0 EDGAR
2021-06-02 AGIO Exer (M) +1,686 $0 EDGAR
2021-05-24 AGIO Grant (A) $0 EDGAR
2020-06-12 EDIT Grant (A) $0 EDGAR
2020-06-09 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Grant (A) $0 EDGAR
2020-06-01 AGIO Mixed +1,878 $0 EDGAR
2019-06-11 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Grant (A) $0 EDGAR
2019-05-31 AGIO Mixed +1,400 $0 EDGAR
2019-02-07 EDIT Grant (A) $0 EDGAR
2018-06-27 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Mixed +34,676 $99.0K EDGAR
Showing 2130 of 34
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.